← BackElectromed, Inc. · Electromedical & Electrotherapeutic ApparatusELMD
Low riskNext report: Nov 10 (confirmed)
The short versionA high-quality, profitable business with growing sales. Institutions are adding.
Going well
- Sales up 12% in the latest quarter vs a year ago
- Profitable every year for 10 years
- Sales up 17% last year
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 4% to their holdings in the quarter ending June 2026 (74 bought, 38 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$26.67+1.2% that day
- Company value
- $223M
- Share price times all shares
- Price vs profit (P/E)
- 20.4x
- You pay about $20 for each $1 of yearly profit
- Price vs sales
- 3.0x
- Company value is 3.0 times a year of sales
- Cash vs value
- 9%
- Cash as a share of company value
From ELMD's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26 (worked out from yearly totals)$19.4M+12% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $73.8M, up 15% from the 12 months before. Over 5 years, sales grew about 15% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.16.9%
- PassDebt under half of equityNot relying on borrowed money.No debt reported
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.11.8%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$11.1M
- MissShare count not growingNot diluting owners. Falling means buybacks.+1.7% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.78.1%
- Revenue
- $64.0M
- +17.0% vs prior year
- 5-year growth
- +14.5%/yr
- revenue, per year
- Total debt
- None
- 0.00x equity
- Current ratio
- 4.86x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $19.4M
- +11.6% YoY
- EPS
- $0.39
- vs $0.26
- Op. margin
- 19.7%
- +2.2 pts
- Gross margin
- 78.7%
- +0.4 pts
- Free cash flow
- $2.8M
- Share count
- +0.2%
- vs a year ago
Some values are worked out from year-to-date totals in the annual report.
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.5
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+4.0%Institutions added 4.0% to their holdings. 74 bought, 38 sold.
Shares held by institutions4.6M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-0.7%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
No debt reportedShares outstandingLatest reported
8M- Results filedAug 25
- Results filedMay 12
- Results filedFeb 10
- Results filedNov 12, 2025
- Results filedAug 26, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
ARSSep 29 · Form ARS ↗DEFA14ASep 29 · Form DEFA14A ↗Proxy statementSep 29 · Form DEF 14A ↗Shares withheld for taxesJames L. CunniffCEO and President, Director
2,671 shares at $27.10 · $72K
- -2% of holdings
- Now owns 145,080 shares
- Filed 2 days after trade
Stock awardBradley M. NagelChief Financial Officer
4,900 shares
- +26% of holdings
- Now owns 23,864 shares
- Exercise price $27.10
- Filed 2 days after trade
- Also: Shares withheld for taxes
Annual reportAug 25 · Form 10-K ↗Earnings resultsAug 25 · Form 8-K ↗Shares withheld for taxesBradley M. NagelChief Financial Officer
674 shares at $42.30 · $29K
- -3% of holdings
- Now owns 18,964 shares
- Filed 2 days after trade
SoldJames L. CunniffCEO and President, Director
9,700 shares at $36.50 avg ($36.25 to $37.77) · $354K
- -6% of holdings
- Now owns 147,751 shares
- Not a pre-planned sale
- 3 transactions
- Filed 1 day after trade
- Also: Option exercise
Planned insider saleJun 8 · Form 144 ↗SoldBradley M. NagelChief Financial Officer
11,801 shares at $36.35 avg ($36.34 to $37.11) · $429K
- -38% of holdings
- Now owns 19,638 shares
- Not a pre-planned sale
- 2 transactions
- Filed 4 days after trade
- Also: Option exercise
Planned insider saleJun 4 · Form 144 ↗SDMay 29 · Form SD ↗SoldKathleen SkarvanDirector
40,000 shares at $35.48 avg ($34.36 to $37.33) · $1.4M
- -53% of holdings
- Now owns 35,622 shares
- Not a pre-planned sale
- 4 transactions
- Filed 4 days after trade
- Also: Option exercise
Planned insider saleMay 15 · Form 144 ↗